HPLC used to test purity of AIDS vaccine

HPLC used to test purity of AIDS vaccine

T875/0337 Rights Managed

Request low-res file

530 pixels on longest edge, unwatermarked

Request/Download high-res file

Uncompressed file size: 29.0MB

Downloadable file size: 1.3MB

Price image Pricing

Please login to use the price calculator

This image is part of the feature Aids Vaccine



Caption: Testing purity of VaxSyn, an experimental AIDS vaccine, using HPLC (high pressure liquid chromatography). VaxSyn is based on a genetically- engineered, recombinant form of the HIV protein gp160, which is a precursor to one of HIV's surface proteins. VaxSyn contains no attenuated infectious parts of HIV & therefore carries no risk of transmitting AIDS. The vaccine is being developed by MicroGeneSys and is undergoing trials as a treatment of HIV-positive patients & as a potential vaccine against HIV infection.

Release details: Model release not available. Property release not required.

Keywords: aids vaccine, aids vaccine testing, apparatus, chemical, chemist, chemistry, chromatography, equipment, experimental, hplc, industry, protein analysis, proteomics, scientist, technology, vaccine, vaxsyn

Licence fees: A licence fee will be charged for any media (low or high resolution) used in your project.